Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.7526
-0.0814 ( -9.76% ) 497.6K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.7526
Previous close
$0.8340
Volume
497.6K
Market cap
$128.82M
Day range
$0.7520 - $0.8720
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| nt | Quarterly Reports | 1 | Oct 01, 2024 |
| 8-k | 8K-related | 13 | Sep 17, 2024 |
| 8-k | 8K-related | 13 | Sep 11, 2024 |
| 4 | Insider transactions | 1 | Aug 27, 2024 |
| 10-q/a | Quarterly Reports | 77 | Aug 20, 2024 |
| 8-k | 8K-related | 13 | Aug 19, 2024 |
| 4/a | Other | 1 | Aug 16, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Jul 19, 2024 |
| 4/a | Other | 1 | Jul 19, 2024 |